文献速递主动脉外科瓣膜外科

近端主动脉手术中促进止血:PROTECT试验结果

Facilitating Hemostasis After Proximal Aortic Surgery: Results of The PROTECT Trial.
PubMed 文献 · Ann Thorac Surg · 2018-01-12

PROTECT试验将接受主动脉瓣置换、升主动脉置换或主动脉根部置换的患者按2:1随机分配至Tridyne组(n=107)或Gelfoam Plus组(n=51),比较两种止血辅料在主动脉切口及缝合线上的安全性和止血效果。结果显示Tridyne组中位出血时间显著低于Gelfoam Plus组(0 vs 10.0分钟,p<0.0001),即刻止血率(59.4% vs 16.0%,p<0.0001)和主动脉缝合线止血成功率(85.7% vs 40.0%,p<0.0001)均显著更高,两组可能器械相关严重不良事件发生率无显著差异(2.9% vs 8.2%,p=0.2097)。

要点

  • Tridyne组中位出血时间为0分钟,Gelfoam Plus组为10.0分钟(p<0.0001)。
  • Tridyne组即刻止血率59.4%,Gelfoam Plus组16.0%(p<0.0001)。
  • Tridyne组主动脉缝合线止血成功率85.7%,Gelfoam Plus组40.0%(p<0.0001)。

核心结论

  • Tridyne作为常规止血辅助手段用于接受抗凝药物治疗患者的高压血管时,在缩短止血时间、促进即刻和持续止血方面安全有效。

研究设计与样本

  • 随机对照试验,将接受主动脉瓣置换、升主动脉置换或主动脉根部置换的患者按2:1随机分配至Tridyne组(n=107)或Gelfoam Plus组(n=51)。
  • 两组在年龄、性别、种族、病史、体外循环和交叉阻断时长以及处理的缝合线数量方面相似。
  • 缝合线在确认有渗漏后、正式移除阻断钳之前进行处理。

主要发现

  • Tridyne组中位出血时间为0分钟,Gelfoam Plus组为10.0分钟(p<0.0001)。
  • Tridyne组即刻止血率为59.4%,Gelfoam Plus组为16.0%(p<0.0001)。
  • Tridyne组主动脉缝合线止血成功率为85.7%,Gelfoam Plus组为40.0%(p<0.0001)。
  • 临床事件委员会裁定7例患者可能发生器械相关严重不良事件:Tridyne组3例(2.9%),Gelfoam Plus组4例(8.2%)(p=0.2097)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study intended to evaluate the safety and hemostatic efficacy of a novel vascular sealant (Tridyne; Neomend, Inc, Irvine, CA) compared with an accepted adjunctive hemostatic agent applied to aortotomy and sutures lines in cardiovascular operations. METHODS: Patients undergoing aortic valve replacement, ascending aortic replacement, or aortic root replacement were randomly assigned 2:1 to Tridyne (n = 107) or Gelfoam Plus (Baxter Healthcare Corp, Hayward, CA) (n = 51). These groups were similar with regard to age, sex, race, medical history, duration of bypass and cross-clamping, and number of suture lines treated. Suture lines were treated after confirmation of some leakage but before formal removal of the clamp. RESULTS: The median bleeding time was significantly lower for Tridyne versus Gelfoam Plus (0 versus 10.0 minutes, p < 0.0001). Immediate hemostasis was achieved in 59.4% of the Tridyne group versus 16.0% of Gelfoam Plus group (p < 0.0001). A significantly greater proportion of patients in the Tridyne group achieved successful hemostasis at the aortic suture line than patients in the Gelfoam Plus group (85.7% versus 40.0%, p < 0.0001). The Clinical Events Committee adjudicated 7 patients with possible device-related serious adverse events: 3 patients (2.9%) in the Tridyne group and 4 patients (8.2%) in the Gelfoam Plus group (p = 0.2097). CONCLUSIONS: Tridyne was safe and effective when used as an adjunct to conventional hemostasis to treat high-pressure vessels in patients who receive anticoagulation agents, in reducing time to hemostasis, and in promoting both immediate and persistent hemostasis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Khoynezhad A, DelaRosa J, Moon MR, et al. Facilitating Hemostasis After Proximal Aortic Surgery: Results of The PROTECT Trial. Ann Thorac Surg. 2018. PMID: 29337125. doi:10.1016/j.athoracsur.2017.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。